You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CMML-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed
Has Results
  • Myelomonocytic Leukemia
  • Tampa, Florida
  • +5 more
Sep 9, 2022

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)

Withdrawn
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia (CMML)
  • (no location specified)
Aug 9, 2021

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Denmark (Vitamin C, Placebo)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Vitamin C
  • Placebo
  • Aalborg, Denmark
  • +5 more
Sep 27, 2021

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    Apr 4, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Salzburg, Austria
    • +17 more
    Dec 14, 2022

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Helsinki, Finland
    • +3 more
    Jun 29, 2022

    MDS, CMML Trial in Florence (CC-486)

    Recruiting
    • MDS
    • CMML
    • Florence, Italy
      AOU Careggi- University of Florence
    Mar 16, 2021

    MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • +2 more
    • Birmingham, Alabama
    • +58 more
    Aug 24, 2022

    MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jul 30, 2023

    Registry on Hypomethylating Agents in Myeloid Neoplasms

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • +2 more
    • non interventional
    • Feldkirch, Austria
    • +19 more
    Jul 20, 2021

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myelomonocytic, Chronic
    • Duarte, California
    • +95 more
    Sep 1, 2021

    Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

    Not yet recruiting
    • Hematologic Malignancy
    • BC3402 Injection
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Jinan University
    Jan 10, 2023

    Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

    Active, not recruiting
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • Daphne, Alabama
    • +241 more
    Dec 23, 2022